Ernest Pharmaceuticals announces FDA INTERACT meeting for EBT-302, a bacterial therapy ...

This productive discussion with FDA reviewers gives Ernest leadership renewed confidence our development plan is on the ...

Suffescom Expands AI Capabilities with Launch of AI Companion Platform

Continues to develop and enhance its AI capabilities to deliver effective, personalized, and engaging experiences through AI chatbots. DE, UNITED STATES, February 6, 2026 /EINPresswire.com/ — ...